Future gazing in the management of multiply drug-resistant Gram-positive infection.
Gram-positive bacteria have evolved to become predominant health care associated pathogens. To meet this challenge, novel approaches to the development, prescribing, and control of antibiotics will be needed. Additional infection control methods must also be explored. This review discusses the challenges posed in particular by methicillin-resistant staphylococci and potential ways forward.
Wilcox
Mark H
MH
Department of Microbiology, Leeds Teaching Hospitals NHS Trust and Institute of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Mark.Wilcox@leedsth.nhs.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D024901:Drug Resistance, Multiple, Bacterial; D019353:Endemic Diseases; D005544:Forecasting; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000472:pathogenicity; D019990:Perioperative Care
D000900:Anti-Bacterial Agents